BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7616107)

  • 1. Bicarbonate and phosphate ions protect transferrin from myeloperoxidase-mediated damage.
    Edeker BL; Rasmussen GT; Britigan BE
    J Leukoc Biol; 1995 Jul; 58(1):59-64. PubMed ID: 7616107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of transferrin iron binding capacity by the neutrophil myeloperoxidase system.
    Clark RA; Pearson DW
    J Biol Chem; 1989 Jun; 264(16):9420-7. PubMed ID: 2542309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibilities of lactoferrin and transferrin to myeloperoxidase-dependent loss of iron-binding capacity.
    Winterbourn CC; Molloy AL
    Biochem J; 1988 Mar; 250(2):613-6. PubMed ID: 2833250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation.
    Britigan BE; Edeker BL
    J Clin Invest; 1991 Oct; 88(4):1092-102. PubMed ID: 1655825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of monovalent anions to human serum transferrin.
    Harris WR; Cafferty AM; Abdollahi S; Trankler K
    Biochim Biophys Acta; 1998 Apr; 1383(2):197-210. PubMed ID: 9602126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of anions with native and phenylglyoxal-modified human serum transferrin.
    Penner MH; Osuga DT; Meares CF; Feeney RE
    Arch Biochem Biophys; 1987 Jan; 252(1):7-14. PubMed ID: 3028261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of inorganic anions on the formation and stability of Fe3+-transferrin-anion complexes.
    Foley AA; Bates GW
    Biochim Biophys Acta; 1988 May; 965(2-3):154-62. PubMed ID: 2835112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.
    Pekoe G; Van Dyke K; Mengoli H; Peden D; English D
    Agents Actions; 1982 Apr; 12(1-2):232-8. PubMed ID: 6282074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase-derived hypochlorous acid antagonizes the oxidative stress-mediated activation of iron regulatory protein 1.
    Mütze S; Hebling U; Stremmel W; Wang J; Arnhold J; Pantopoulos K; Mueller S
    J Biol Chem; 2003 Oct; 278(42):40542-9. PubMed ID: 12888561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acid.
    Shaeib F; Khan SN; Ali I; Najafi T; Maitra D; Abdulhamid I; Saed GM; Pennathur S; Abu-Soud HM
    PLoS One; 2015; 10(3):e0120737. PubMed ID: 25835505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion and inactivation of myeloperoxidase by isolated neutrophils.
    King CC; Jefferson MM; Thomas EL
    J Leukoc Biol; 1997 Mar; 61(3):293-302. PubMed ID: 9060452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of peroxidase-catalyzed reactions by deferoxamine.
    Klebanoff SJ; Waltersdorph AM
    Arch Biochem Biophys; 1988 Aug; 264(2):600-6. PubMed ID: 2840860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic studies on anion binding to apotransferrin and to recombinant transferrin N-lobe half molecules.
    Harris WR; Cafferty AM; Trankler K; Maxwell A; MacGillivray RT
    Biochim Biophys Acta; 1999 Mar; 1430(2):269-80. PubMed ID: 10082955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anion binding properties of the transferrins. Implications for function.
    Harris WR
    Biochim Biophys Acta; 2012 Mar; 1820(3):348-61. PubMed ID: 21846492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway.
    Maitra D; Shaeib F; Abdulhamid I; Abdulridha RM; Saed GM; Diamond MP; Pennathur S; Abu-Soud HM
    Free Radic Biol Med; 2013 Oct; 63():90-8. PubMed ID: 23624305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin modifications and lipid peroxidation: implications in diabetes mellitus.
    van Campenhout A; van Campenhout CM; Lagrou AR; Manuel-y-Keenoy B
    Free Radic Res; 2003 Oct; 37(10):1069-77. PubMed ID: 14703796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of anion binding to human serum transferrin.
    Harris WR
    Biochemistry; 1985 Dec; 24(25):7412-8. PubMed ID: 3853465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Myeloperoxidase- and Neutrophil-Mediated Hypochlorous Acid Formation in Vitro and Endothelial Cell Injury by (-)-Epigallocatechin Gallate.
    Tian R; Ding Y; Peng YY; Lu N
    J Agric Food Chem; 2017 Apr; 65(15):3198-3203. PubMed ID: 28361543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury.
    de Vries B; Walter SJ; von Bonsdorff L; Wolfs TG; van Heurn LW; Parkkinen J; Buurman WA
    Transplantation; 2004 Mar; 77(5):669-75. PubMed ID: 15021827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitive Effects of Quercetin on Myeloperoxidase-Dependent Hypochlorous Acid Formation and Vascular Endothelial Injury.
    Lu N; Sui Y; Tian R; Peng YY
    J Agric Food Chem; 2018 May; 66(19):4933-4940. PubMed ID: 29708335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.